sym-trinitrobenzene has been researched along with Pulmonary Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, H; Stein-Streilein, J | 1 |
1 other study(ies) available for sym-trinitrobenzene and Pulmonary Fibrosis
| Article | Year |
|---|---|
Hapten-immune pulmonary interstitial fibrosis (HIPIF) in mice requires both CD4+ and CD8+ T lymphocytes.
Topics: Animals; Antibodies, Monoclonal; Antigens; CD4-Positive T-Lymphocytes; CD8 Antigens; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Haptens; Hydroxyproline; Immunotherapy, Adoptive; Lung; Lymphocyte Depletion; Mice; Mice, Inbred BALB C; Pulmonary Fibrosis; T-Lymphocytes; Trinitrobenzenes | 1993 |